Epistatus now has a licence!
Epistatus has now been granted a licence for the use in 10-18 year old people diagnosed with epilepsy, see the […]
Author Archives: Phil Tittensor
Prescribing day conference 2017!!
The bi-annual prescribing day is being held on the 21st June 2017 at the Paragon Hotel in Birmingham. Draft agenda […]
Buccolam leaflets and video
ESNA have been working with Shire and their promotional company Accretio to improve support materials for Buccolam, the licensed oral […]
epilepsy care articles
Do you have something you would like published? It is the peer review journal from ESNA. We offer £200 per […]
ESNA Conference 2016 – feedback
We recently held our bi-annual conference in Manchester. This two-day event was very well attended and featured a faculty that […]
ESNA Executive minutes, April 2016
ESNA Conference, Manchester 19th and 20th June 2016
We are delighted to announce the programme for our biennial conference, which this year will take place in Manchester. We […]
New SIGN guidelines for epilepsy launched.
The Scottish Intercollegiate Guidelines Network (SIGN) have recently produced a new and updated clinical guideline for the Diagnosis and management […]
Website terms and conditions
The ESNA website is covered by a disclaimer and protected by copyright laws. This website is for information purposes only. […]
Epilepsy debate in the House of Commons, Thursday 26 February 2015 – we need your help!
A parliamentary debate on epilepsy is set to take place in the House of Commons on Thursday 26 February 2015 […]
Further information on valproate
Following on from last weeks announcement, here is some further information about the updated guidance for the use of valproate […]
More guidence on Valproate
On the 9th February 2015, NHS England issued the attached communique to further reinforce the strengthened teratogenicity warnings concerning Valproate […]